The GPI-Linked Protein LY6A Drives AAV-PHP.B Transport across the Blood-Brain Barrier

Molecular Therapy : the Journal of the American Society of Gene Therapy
Juliette HordeauxJames M Wilson

Abstract

Efficient delivery of gene therapy vectors across the blood-brain barrier (BBB) is the holy grail of neurological disease therapies. A variant of the neurotropic vector adeno-associated virus (AAV) serotype 9, called AAV-PHP.B, was shown to very efficiently deliver transgenes across the BBB in C57BL/6J mice. Based on our recent observation that this phenotype is mouse strain dependent, we used whole-exome sequencing-based genetics to map this phenotype to a specific haplotype of lymphocyte antigen 6 complex, locus A (Ly6a) (stem cell antigen-1 [Sca-1]), which encodes a glycosylphosphatidylinositol (GPI)-anchored protein whose function had been thought to be limited to the biology of hematopoiesis. Additional biochemical and genetic studies definitively linked high BBB transport to the binding of AAV-PHP.B with LY6A (SCA-1). These studies identify, for the first time, a ligand for this GPI-anchored protein and suggest a role for it in BBB transport that could be hijacked by viruses in natural infections or by gene therapy vectors to treat neurological diseases.

Citations

Jul 13, 2019·Human Gene Therapy·Pasqualina Colella, Federico Mingozzi
Nov 22, 2019·Human Gene Therapy. Clinical Development·Ting HeChengwen Li
Feb 27, 2020·Journal of Internal Medicine·C Viscomi, M Zeviani
May 16, 2020·Brain : a Journal of Neurology·Robin Reynaud-DulaurierMichael Decressac
Aug 18, 2020·Human Gene Therapy·Ana CarneiroDavid V Schaffer
May 2, 2020·Nature Communications·Jai Woong SeoKatherine W Ferrara
Mar 7, 2020·Fluids and Barriers of the CNS·Richard F KeepLester R Drewes
Dec 19, 2019·Frontiers in Neuroanatomy·Leila HaeryMelina Fan
Apr 22, 2020·Nature Methods·Sripriya Ravindra KumarViviana Gradinaru
Aug 9, 2020·Frontiers in Molecular Neuroscience·Andrew P Tosolini, James N Sleigh
Nov 18, 2020·Metabolic Brain Disease·Dan LiuYong Diao
Dec 19, 2020·Pharmaceutics·Seigo Kimura, Hideyoshi Harashima
Nov 27, 2020·Journal of Neuroscience Methods·Antonio LuchicchiNathan Marchant
Nov 13, 2020·Frontiers in Bioengineering and Biotechnology·Robin Reynaud-Dulaurier, Michael Decressac
Feb 9, 2021·Frontiers in Cellular Neuroscience·Assumpció Bosch, Raúl Estévez
Feb 9, 2021·Molecular Therapy. Methods & Clinical Development·Mathieu NonnenmacherJay Hou
Mar 3, 2021·Nature Reviews. Drug Discovery·Georg C TerstappenWandong Zhang
Nov 24, 2019·Biochemical and Biophysical Research Communications·Ayumu InutsukaTatsushi Onaka
Mar 30, 2021·Journal of Controlled Release : Official Journal of the Controlled Release Society·Wenli ChenXiaochun Zhang
Feb 28, 2020·Molecular Therapy : the Journal of the American Society of Gene Therapy·Kathleen BörnerDirk Grimm
Apr 18, 2021·Trends in Pharmacological Sciences·Cole W PetersKillian S Hanlon
Aug 19, 2020·Journal of Neuroscience Methods·Ayumu Konno, Hirokazu Hirai
Apr 24, 2021·Nature Biotechnology·Malorye Branca
Apr 26, 2021·Trends in Molecular Medicine·Danqing ZhuDavid V Schaffer
Jun 26, 2021·Molecular Therapy. Methods & Clinical Development·Francis J MayCharles P Venditti
Jul 10, 2021·Frontiers in Cellular Neuroscience·Georg von JonquieresGary D Housley
Oct 27, 2020·Current Topics in Medicinal Chemistry·Josep GarciaMeritxell Teixidó
Aug 20, 2021·Life Science Alliance·Cristin D DavidsonWilliam J Pavan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell-Type Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Cell-Type-Specific Viral Vectors (ASM)

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

AAV-based Gene Therapy

Adeno-associated virus (AAV)-based gene therapy is a biological vector that is being researched to be used as a potential therapeutic option. This gene therapy is designed to insert fragments of DNA into targeted cells to help treat diseases, such as hemophilia a. Discover the latest research on AAV-based gene therapy here.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Cell-Type-Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.